These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 17312098)

  • 21. Unique tumor antigens: evidence for immune control of genome integrity and immunogenic targets for T cell-mediated patient-specific immunotherapy.
    Sensi M; Anichini A
    Clin Cancer Res; 2006 Sep; 12(17):5023-32. PubMed ID: 16951217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer immunology--an overview.
    Richards V
    Prog Exp Tumor Res; 1980; 25():1-60. PubMed ID: 6986628
    [No Abstract]   [Full Text] [Related]  

  • 23. [Identification of tumor antigens: strategies and perspectives].
    Zippelius A; Knights A; Tinguely M; Jäger D; Renner C; Knuth A
    Dtsch Med Wochenschr; 2006 Aug; 131(33):1809-12. PubMed ID: 16902905
    [No Abstract]   [Full Text] [Related]  

  • 24. [Tumor specific antigen and cytotoxic T lymphocytes].
    Uenaka A; Nakayama E
    Nihon Rinsho; 2005 Apr; 63 Suppl 4():568-73. PubMed ID: 15861712
    [No Abstract]   [Full Text] [Related]  

  • 25. [Immunology: new approaches to immuno-modulation and immunotherapy].
    Kabelitz D
    Dtsch Med Wochenschr; 2006 Jun; 131(25-26):1471-3. PubMed ID: 16794979
    [No Abstract]   [Full Text] [Related]  

  • 26. Nobel's day on recent advances in cancer research.
    Mantovani A
    Ann Oncol; 1993 Jan; 4(1):35-6. PubMed ID: 8435359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human tumour antigens recognized by T cells: new perspectives for anti-cancer vaccines?
    Coulie PG
    Mol Med Today; 1997 Jun; 3(6):261-8. PubMed ID: 9211417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Olivera Finn profile. Directing a life in science.
    Leslie M
    Science; 2008 Aug; 321(5891):906-7. PubMed ID: 18703719
    [No Abstract]   [Full Text] [Related]  

  • 29. Proteogenomics meets cancer immunology: mass spectrometric discovery and analysis of neoantigens.
    Polyakova A; Kuznetsova K; Moshkovskii S
    Expert Rev Proteomics; 2015; 12(5):533-41. PubMed ID: 26175083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [NY-ESO-1 and cancer immunotherapy].
    Peng JR; Leng XS
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Aug; 30(4):371-7. PubMed ID: 18795604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genes coding for tumor rejection antigens: perspectives for specific immunotherapy.
    Boon T; Coulie P; Marchand M; Weynants P; Wölfel T; Brichard V
    Important Adv Oncol; 1994; ():53-69. PubMed ID: 8206495
    [No Abstract]   [Full Text] [Related]  

  • 32. [Technological advances in immuno-oncology: from fundamental concepts to patient immunological monitoring].
    Chouaib S; Echchakir H; Angevin E; Guerra N; Kosmatopoulos K; Caignard A; Lim A; Baron V; Ferradini L; Mami-Chouaib F
    Bull Cancer; 2001 Aug; 88(8):733-40. PubMed ID: 11578941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The function of tumor specific antigen (MAGE) in tumor immunotherapy].
    Fang JB; Wang L
    Sheng Li Ke Xue Jin Zhan; 2005 Jul; 36(3):273-5. PubMed ID: 16270835
    [No Abstract]   [Full Text] [Related]  

  • 34. Neoantigens encoded in the cancer genome.
    Schumacher TN; Hacohen N
    Curr Opin Immunol; 2016 Aug; 41():98-103. PubMed ID: 27518850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Personalized cancer vaccines.
    Jain KK
    Expert Opin Biol Ther; 2010 Dec; 10(12):1637-47. PubMed ID: 20979567
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Towards a cancer immunome database.
    Jongeneel V
    Cancer Immun; 2001 Mar; 1():3. PubMed ID: 12747764
    [No Abstract]   [Full Text] [Related]  

  • 37. [New aspects of human cancer immunology].
    Kikuchi K
    Nihon Seikeigeka Gakkai Zasshi; 1997 Jul; 71(7):292-303. PubMed ID: 9276876
    [No Abstract]   [Full Text] [Related]  

  • 38. [Study of the etiology and immunology of tumors. 1955].
    Zil'ber LA
    Vopr Onkol; 2005; 51(2):148-53. PubMed ID: 16222992
    [No Abstract]   [Full Text] [Related]  

  • 39. Rekindling cancer vaccines.
    Branca MA
    Nat Biotechnol; 2016 Oct; 34(10):1019-1024. PubMed ID: 27727216
    [No Abstract]   [Full Text] [Related]  

  • 40. Introduction: Cancer Immunology Special Issue-Immunopathology.
    Kawakami Y
    Int Immunol; 2016 Aug; 28(8):371. PubMed ID: 27450690
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.